McKesson Long Term Debt 2010-2022 | MCK

McKesson long term debt from 2010 to 2022. Long term debt can be defined as the sum of all long term debt fields.
  • McKesson long term debt for the quarter ending June 30, 2022 was $12.108B, a 13.64% decline year-over-year.
  • McKesson long term debt for 2022 was $12.3B, a 15.01% decline from 2021.
  • McKesson long term debt for 2021 was $14.473B, a 128.46% increase from 2020.
  • McKesson long term debt for 2020 was $6.335B, a 12.8% decline from 2019.
McKesson Annual Long Term Debt
(Millions of US $)
2022 $12,300
2021 $14,473
2020 $6,335
2019 $7,265
2018 $6,751
2017 $7,305
2016 $6,497
2015 $8,180
2014 $8,929
2013 $4,521
2012 $3,072
2011 $3,587
2010 $2,293
2009 $2,290
McKesson Quarterly Long Term Debt
(Millions of US $)
2022-06-30 $12,108
2022-03-31 $12,300
2021-12-31 $12,671
2021-09-30 $13,092
2021-06-30 $14,020
2021-03-31 $14,473
2020-12-31 $14,534
2020-09-30 $5,848
2020-06-30 $6,395
2020-03-31 $6,335
2019-12-31 $6,734
2019-09-30 $7,342
2019-06-30 $7,382
2019-03-31 $7,265
2018-12-31 $7,616
2018-09-30 $6,568
2018-06-30 $6,592
2018-03-31 $6,751
2017-12-31 $7,514
2017-09-30 $7,490
2017-06-30 $7,424
2017-03-31 $7,305
2016-12-31 $5,969
2016-09-30 $5,941
2016-06-30 $5,942
2016-03-31 $6,497
2015-12-31 $7,715
2015-09-30 $8,136
2015-06-30 $8,142
2015-03-31 $8,180
2014-12-31 $8,981
2014-09-30 $9,620
2014-06-30 $10,141
2014-03-31 $8,929
2013-12-31 $4,521
2013-09-30 $4,521
2013-06-30 $4,522
2013-03-31 $4,521
2012-12-31 $3,973
2012-09-30 $3,073
2012-06-30 $3,072
2012-03-31 $3,072
2011-12-31 $3,578
2011-09-30 $3,578
2011-06-30 $3,575
2011-03-31 $3,587
2010-12-31 $2,305
2010-09-30 $2,279
2010-06-30 $2,278
2010-03-31 $2,293
2009-12-31 $2,294
2009-09-30 $2,294
2009-06-30 $2,292
2009-03-31 $2,290
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $50.991B $263.966B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $72.810B 21.15
AmerisourceBergen (ABC) United States $30.314B 13.39
West Pharmaceutical Services (WST) United States $24.398B 37.15
Laboratory Of America Holdings (LH) United States $23.439B 10.25
Cardinal Health (CAH) United States $16.828B 12.92
Cooper (COO) United States $16.065B 24.73
CONMED (CNMD) United States $2.967B 29.25
Invacare (IVC) United States $0.033B 0.00